title: Administration of porcine interleukin-3 induces increased levels of blood eosinophils.
abstract: Increasing resistance to anthelmintic drugs indicates a vital need to develop alternative strategies to control helminth infections. Interleukin-3 (IL-3) is a multilineage hematopoietic growth regulator produced by activated T lymphocytes in response to infection. In helminth infections, eosinophils play an important role in the elimination of parasites through their recruitment of inflammatory cells and the release of granules. The ability of IL-3 to stimulate the development of eosinophils makes it a particularly important candidate for therapeutic use to protect against parasites. To enable the role of IL-3 in the development, growth, and differentiation of porcine eosinophils to be elucidated, recombinant IL-3 (rPoIL-3) was expressed and purified. As the amino acid sequence identities between porcine IL-3 and other reported species were quite low ( approximately 39% between human and pig), an assessment of the in vitro activity of rPoIL-3 was made. The culture of porcine bone marrow (BM) cells with rPoIL-3 stimulated the proliferation of SWC3a(hi) myeloid cells, conA rming that rPoIL-3 acted as a hematopoietic cell growth factor. Since rPoIL-3 stimulated the development of myeloid cells in culture, the in vivo potential to produce elevated eosinophil proportions was assessed. In vivo administration of rPoIL-3 induced a signiA cant increase in the number of eosinophils in blood. These results suggest that rPoIL-3 is a potent inducer of eosinophils in swine and supports the inclusion of rPoIL-3 in therapeutic strategies.
authors.affiliation: CSIRO, Livestock Industries, Australian Animal Heath Laboratory (AAHL), Geelong, Victoria, Australia. kirsten.morris@csiro.au
authors.forename: Kirsten R
authors.initials: KR
authors.lastname: Morris
authors.forename: Andrew G D
authors.initials: AG
authors.lastname: Bean
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Bruce
authors.forename: Mary M
authors.initials: MM
authors.lastname: Broadway
authors.forename: Terri E
authors.initials: TE
authors.lastname: O'Neil
authors.forename: Marion E
authors.initials: ME
authors.lastname: Andrew
authors.forename: John J
authors.initials: JJ
authors.lastname: Emmins
authors.forename: David G
authors.initials: DG
authors.lastname: Strom
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D002417:Cattle; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D004804:Eosinophils / Q000166:cytology* / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007377:Interleukin-3 / Q000008:administration & dosage* / Q000276:immunology; D007958:Leukocyte Count; D051379:Mice; D008954:Models, Biological; D008968:Molecular Conformation; D010272:Parasitic Diseases / Q000097:blood / Q000188:drug therapy; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000276:immunology; D020539:Sequence Analysis, Protein; D012756:Sheep; D013552:Swine
chemical_list: D007377:Interleukin-3; D011994:Recombinant Proteins